NASDAQ:CRBP Stock Quote
5.5200
-0.2700 (-4.66%)
Corbus Pharmaceuticals Holdings Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies to treat rare and chronic inflammatory diseases
The company specializes in cannabinoid-based treatments and aims to address unmet medical needs through its research and development efforts. Corbus is dedicated to advancing its pipeline of drug candidates, leveraging its expertise in pharmaceuticals to improve patient outcomes and enhance the quality of life for those suffering from challenging health conditions.
